Benicar MDL Plaintiffs Can't Depose Foreign Witnesses

Law360, New York (September 28, 2016, 8:36 PM EDT) -- Litigants suing over adverse effects of the blood pressure drug Benicar can’t compel testimony from employees of drugmaker Daiichi Sankyo's European unit, a New Jersey federal judge ruled Wednesday, citing the legal limits on deposing employees of a subsidiary that’s not a party to the case.

The plaintiffs in the centralized litigation had sought to depose the two highest-level members Daiichi Sankyo Europe GmbH’s Clinical Safety and Pharmacovigilance Department, who had extensive involvement in studying intestinal distress induced by olmesartan medoxomil, the drug branded as Benicar. The would-be...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.